---
title: Tumour plasticity and tumour microenvironment interactions as potential immunologic
  targets for pancreatic cancer treatment
date: '2025-01-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39806851/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250114170947&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Pancreatic ductal adenocarcinoma (PDAC) is a malignant cancer with a
  high mortality and limited treatment options. Systemic chemotherapy remains the
  only approach for improving survival in patients with unresectable locally advanced
  and/or metastatic disease which comprises most patients. Targeted therapies have
  so far been disappointing with limited applicability and improvement in overall
  survival. Patients with resectable PDAC have improved survival with adjuvant chemotherapy,
  ...
disable_comments: true
---
Pancreatic ductal adenocarcinoma (PDAC) is a malignant cancer with a high mortality and limited treatment options. Systemic chemotherapy remains the only approach for improving survival in patients with unresectable locally advanced and/or metastatic disease which comprises most patients. Targeted therapies have so far been disappointing with limited applicability and improvement in overall survival. Patients with resectable PDAC have improved survival with adjuvant chemotherapy, ...